FDA Inspection 1309604 — Humacyte Global, Inc
The FDA completed an inspection of Humacyte Global, Inc on February 12, 2026 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 12, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Durham, NC (United States)